Shares of US biopharma Rhythm Pharmaceuticals rose 27.4% to $82.96 in early trading today, as it announced positive top-line ...

Radiant Biotherapeutics, a Canadian biotech advancing multi-specific, multi-affinity antibody (Multabody) therapeutics in ...

US antivirals specialist Gilead Sciences today announced a strategic partnership agreement with the Global Fund to Fight AIDS ...

The US Food and Drug Administration (FDA) has approved a label update with a new recommended titration dosing schedule for ...

Danish drugmaker Novo Nordisk (NOV: N) has filed for European approval of a higher-dose version of its obesity treatment ...

French biotech Ciloa is joining the race to treat type 2 diabetes and obesity, armed with 6.5 million euros ($7.6 million) in ...

Radiopharmaceutical biotech Actithera today announced the close of an oversubscribed $75.5 million Series A financing round.

New Jersey, USA-headquartered Champions Oncology, a translational oncology research organization, yesterday announced the ...

Dutch privately held Amarna Therapeutics, which specializes in transformative gene therapies announced the formalization of ...

US clinical-stage biotech ProKidney reported statistically-significant and clinically-meaningful positive top-line results ...

A new analysis from US data analytics firm Phesi has raised concerns about the viability of ongoing Phase III trials in ...

Donald Trump has escalated his warnings to the pharmaceutical industry with a pledge to introduce import tariffs as high as ...